Guggenheim initiated coverage on Renalytix with a new price target
$RNLX
Medical Specialities
Health Care
Guggenheim initiated coverage of Renalytix with a rating of Buy and set a new price target of $28.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/18/2022 | $30.00 | Buy | HC Wainwright & Co. |
| 1/4/2022 | $24.00 | Buy | BTIG |
| 10/4/2021 | $28.00 | Buy | Guggenheim |
| 7/2/2021 | $38.00 | Buy | Berenberg |